摘要婴儿血管瘤是婴幼儿最常见的良性肿瘤,发病率5%~10%,具有独特的生命周期,1岁内快速生长.部分血管瘤可自然消退,但有些血管瘤生长迅速,损害功能、形成溃疡或威胁生命,仍需积极治疗.目前常见的药物治疗方法,包括系统用药、局部外用药物和局部注射药物.普萘洛尔等β受体阻滞剂因其独特优点已逐渐成为首选方法,糖皮质激素仍是治疗血管瘤的重要方法.目前婴幼儿血管瘤的治疗已呈现出多种药物综合治疗的趋势,同时可联合激光治疗.临床中应根据血管瘤的类型、部位、大小、深浅、分布等选择不同的治疗方法.
更多相关知识
abstractsInfantile hemangiomas (IHs) are the most common benign tumor in infants with an incidence of 5%-10%.They have a characteristic natural course,and proliferate rapidly within 1 year after birth.Some hemangiomas subside spontaneously,but some grow rapidly,causing functional impairment with ulcer formation and even threatening life,and require active treatment.At present,pharmacotherapy strategies commonly include systemic drugs,topical drugs and locally injected drugs.Although β-receptor blockers such as propranolol have gradually become the preferred drugs for their unique advantages,glucocorticoids are still an important approach to the treatment of hemangiomas.Recently,there has been a trend towards comprehensive treatment of IHs with various drugs alone or in combination with lasers.In clinic,therapeutic methods should be chosen based on type,location,size,depth and distribution of hemangiomas.
More相关知识
- 浏览290
- 被引9
- 下载383

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文